Why This S&P 500 Stock Is Defying the Brutal Coronavirus Plunge
Gilead Sciences stock was one of just a handful of S&P 500 companies in the green on Monday. Investors are hopeful that remdesivir could be a treatment for the coronavirus GILD’s bounce is just a taste of the upside it could experience if it develops an effective treatment. As most of the U.S. stock market…